Complete Blood Cell Count (CBC) with Differential, Blood
Use
This test serves as a screening tool to confirm a hematologic disorder, establish or rule out a diagnosis, detect an unsuspected hematologic disorder, or monitor effects of radiation or chemotherapy. It evaluates the counts and qualities of blood cells, providing clinical insights into the patient's hematologic health and aiding in the diagnosis or monitoring of diseases.
Special Instructions
If not ordering electronically, complete, print, and send a Kidney Transplant Test Request with the specimen. A morphology evaluation or peripheral blood smear review is performed additionally when necessary, incurring extra charges.
Limitations
Results may be influenced by improper specimen collection and handling, inappropriate test selection, and interfering substances. Questionable results are flagged for potential review by pathologists using a detailed evaluation process.
FDA ApprovedNew York Approved
Methodology
Automated Analyzer (Hematology)
Biomarkers
LOINC Codes
- 57021-8
- 718-7
- 4544-3
- 789-8
- 787-2
- 788-0
- 6690-2
- 751-8
- 731-0
- 742-7
- 711-2
- 704-7
- 777-3
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3 mL
Minimum Volume
1.5 mL
Container
Lavender top (EDTA)
Causes for Rejection
Gross hemolysis, clotted specimens
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 48 hours |